Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension

Jeremy D. Fields, Parisa P. Javedani, Julie Falardeau, Gary Nesbit, Aclan Dogan, Erek Helseth, Kenneth C. Liu, Stanley L. Barnwell, Bryan Petersen

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background: Lumboperitoneal shunt (LPS), ventriculoperitoneal shunt (VPS) and optic nerve sheath fenestration (ONSF) are accepted surgical therapies for medically refractory idiopathic intracranial hypertension (IIH). In the subset of patients with IIH and venous sinus stenosis, dural venous sinus stenting has emerged as an alternative surgical approach. Methods: All cases of dural stents for IIH at our institution were retrospectively reviewed. Eligibility criteria included medically refractory IIH with documented papilledema and dural venous sinus stenosis of the dominant venous outflow system (gradient ≥10 mm Hg). Results: Fifteen cases (all women) of mean age 34 years were identified. All had failed medical therapy and six had failed surgical intervention. Technical success was achieved in all patients without major periprocedural complications. The mean preprocedural gradient across the venous stenosis was reduced from 24 mm Hg before the procedure to 4 mm Hg after the procedure. Headache resolved or improved in 10 patients. Papilledema resolved in all patients and visual acuity stabilized or improved in 14 patients. There were no instances of restenosis among the 14 patients with follow-up imaging. Conclusion: In this small case series, dural sinus stenting for IIH was performed safely with a high degree of technical success and with excellent clinical outcomes. These results suggest that angioplasty and stenting for the treatment of medically refractory IIH in patients with dural sinus stenosis warrants further investigation as an alternative to LPS, VPS and ONSF.

Original languageEnglish (US)
Pages (from-to)62-68
Number of pages7
JournalJournal of NeuroInterventional Surgery
Volume5
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Pseudotumor Cerebri
Angioplasty
Pathologic Constriction
Ventriculoperitoneal Shunt
Optic Nerve
Therapeutics
Patient Acuity
Papilledema
Visual Acuity
Stents
Headache

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension. / Fields, Jeremy D.; Javedani, Parisa P.; Falardeau, Julie; Nesbit, Gary; Dogan, Aclan; Helseth, Erek; Liu, Kenneth C.; Barnwell, Stanley L.; Petersen, Bryan.

In: Journal of NeuroInterventional Surgery, Vol. 5, No. 1, 01.2013, p. 62-68.

Research output: Contribution to journalArticle

Fields, Jeremy D. ; Javedani, Parisa P. ; Falardeau, Julie ; Nesbit, Gary ; Dogan, Aclan ; Helseth, Erek ; Liu, Kenneth C. ; Barnwell, Stanley L. ; Petersen, Bryan. / Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension. In: Journal of NeuroInterventional Surgery. 2013 ; Vol. 5, No. 1. pp. 62-68.
@article{2976b5f0ed194ee9a771fe95a4effa57,
title = "Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension",
abstract = "Background: Lumboperitoneal shunt (LPS), ventriculoperitoneal shunt (VPS) and optic nerve sheath fenestration (ONSF) are accepted surgical therapies for medically refractory idiopathic intracranial hypertension (IIH). In the subset of patients with IIH and venous sinus stenosis, dural venous sinus stenting has emerged as an alternative surgical approach. Methods: All cases of dural stents for IIH at our institution were retrospectively reviewed. Eligibility criteria included medically refractory IIH with documented papilledema and dural venous sinus stenosis of the dominant venous outflow system (gradient ≥10 mm Hg). Results: Fifteen cases (all women) of mean age 34 years were identified. All had failed medical therapy and six had failed surgical intervention. Technical success was achieved in all patients without major periprocedural complications. The mean preprocedural gradient across the venous stenosis was reduced from 24 mm Hg before the procedure to 4 mm Hg after the procedure. Headache resolved or improved in 10 patients. Papilledema resolved in all patients and visual acuity stabilized or improved in 14 patients. There were no instances of restenosis among the 14 patients with follow-up imaging. Conclusion: In this small case series, dural sinus stenting for IIH was performed safely with a high degree of technical success and with excellent clinical outcomes. These results suggest that angioplasty and stenting for the treatment of medically refractory IIH in patients with dural sinus stenosis warrants further investigation as an alternative to LPS, VPS and ONSF.",
author = "Fields, {Jeremy D.} and Javedani, {Parisa P.} and Julie Falardeau and Gary Nesbit and Aclan Dogan and Erek Helseth and Liu, {Kenneth C.} and Barnwell, {Stanley L.} and Bryan Petersen",
year = "2013",
month = "1",
doi = "10.1136/neurintsurg-2011-010156",
language = "English (US)",
volume = "5",
pages = "62--68",
journal = "Journal of NeuroInterventional Surgery",
issn = "1759-8478",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension

AU - Fields, Jeremy D.

AU - Javedani, Parisa P.

AU - Falardeau, Julie

AU - Nesbit, Gary

AU - Dogan, Aclan

AU - Helseth, Erek

AU - Liu, Kenneth C.

AU - Barnwell, Stanley L.

AU - Petersen, Bryan

PY - 2013/1

Y1 - 2013/1

N2 - Background: Lumboperitoneal shunt (LPS), ventriculoperitoneal shunt (VPS) and optic nerve sheath fenestration (ONSF) are accepted surgical therapies for medically refractory idiopathic intracranial hypertension (IIH). In the subset of patients with IIH and venous sinus stenosis, dural venous sinus stenting has emerged as an alternative surgical approach. Methods: All cases of dural stents for IIH at our institution were retrospectively reviewed. Eligibility criteria included medically refractory IIH with documented papilledema and dural venous sinus stenosis of the dominant venous outflow system (gradient ≥10 mm Hg). Results: Fifteen cases (all women) of mean age 34 years were identified. All had failed medical therapy and six had failed surgical intervention. Technical success was achieved in all patients without major periprocedural complications. The mean preprocedural gradient across the venous stenosis was reduced from 24 mm Hg before the procedure to 4 mm Hg after the procedure. Headache resolved or improved in 10 patients. Papilledema resolved in all patients and visual acuity stabilized or improved in 14 patients. There were no instances of restenosis among the 14 patients with follow-up imaging. Conclusion: In this small case series, dural sinus stenting for IIH was performed safely with a high degree of technical success and with excellent clinical outcomes. These results suggest that angioplasty and stenting for the treatment of medically refractory IIH in patients with dural sinus stenosis warrants further investigation as an alternative to LPS, VPS and ONSF.

AB - Background: Lumboperitoneal shunt (LPS), ventriculoperitoneal shunt (VPS) and optic nerve sheath fenestration (ONSF) are accepted surgical therapies for medically refractory idiopathic intracranial hypertension (IIH). In the subset of patients with IIH and venous sinus stenosis, dural venous sinus stenting has emerged as an alternative surgical approach. Methods: All cases of dural stents for IIH at our institution were retrospectively reviewed. Eligibility criteria included medically refractory IIH with documented papilledema and dural venous sinus stenosis of the dominant venous outflow system (gradient ≥10 mm Hg). Results: Fifteen cases (all women) of mean age 34 years were identified. All had failed medical therapy and six had failed surgical intervention. Technical success was achieved in all patients without major periprocedural complications. The mean preprocedural gradient across the venous stenosis was reduced from 24 mm Hg before the procedure to 4 mm Hg after the procedure. Headache resolved or improved in 10 patients. Papilledema resolved in all patients and visual acuity stabilized or improved in 14 patients. There were no instances of restenosis among the 14 patients with follow-up imaging. Conclusion: In this small case series, dural sinus stenting for IIH was performed safely with a high degree of technical success and with excellent clinical outcomes. These results suggest that angioplasty and stenting for the treatment of medically refractory IIH in patients with dural sinus stenosis warrants further investigation as an alternative to LPS, VPS and ONSF.

UR - http://www.scopus.com/inward/record.url?scp=84871410225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871410225&partnerID=8YFLogxK

U2 - 10.1136/neurintsurg-2011-010156

DO - 10.1136/neurintsurg-2011-010156

M3 - Article

VL - 5

SP - 62

EP - 68

JO - Journal of NeuroInterventional Surgery

JF - Journal of NeuroInterventional Surgery

SN - 1759-8478

IS - 1

ER -